XML 18 R6.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended 12 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Dec. 31, 2021
Operating activities            
Net income $ 81,837 $ 61,634 $ 196,206 $ 144,427    
Adjustments to reconcile net income to net cash provided by in operating activities:            
Share-based compensation     26,956 17,174    
Depreciation and amortization 2,700 2,000 8,152 3,931    
Amortization of intangibles 20,341 27,193 56,011 38,596    
Amortization of debt discount     5,476 6,007    
Amortization of (premium) discounts on marketable securities, net     (3,830) 985    
Realized loss on marketable securities     0 1,727    
Loss on disposal of equipment     517 80    
Contingent liability fair value measurement adjustment (13,200) 0 (13,200) 0    
Recognition of deferred revenue     (2,579) (1,573)    
Lease payments recognized (deferred)     0 (638)    
Induced conversion expense related to convertible notes 0 2,712 0 2,712 $ 2,700 $ 21,000
Deferred income taxes     25,083 25,329    
Other     0 (228)    
Changes in operating assets and liabilities:            
Accounts receivable, net and other contract assets     13,546 (76,186)    
Inventories     (28,353) (14,536)    
Prepaid expenses and other assets     5,299 (14,359)    
Accounts payable and accrued expenses     (3,067) 24,209    
Net cash provided by operating activities     286,217 157,657    
Investing activities            
Purchases of marketable securities     (271,617) (225,689)    
Proceeds from sales and maturities of marketable securities     195,697 725,995    
Acquisition of business, net of cash acquired     0 (999,120)    
Purchases of property and equipment     (12,698) (2,466)    
Proceeds from the sale of assets     0 16,021    
Net cash used in investing activities     (88,618) (485,259)    
Financing activities            
Proceeds from term loan     0 250,000    
Repayment of term loan     0 (250,000)    
Proceeds from revolving credit facilities     0 120,000    
Repayment of revolving credit facilities     0 (120,000)    
Repayment of 2024 Convertible Notes     (13,483) (77,453)    
Proceeds from issuance of 2028 Convertible Notes     0 702,000    
Purchase of capped call     0 (69,120)    
Payment of debt issuance costs     0 (6,465)    
Repurchase of common stock     (150,083) (200,001)    
Proceeds from issuance of common stock under equity incentive plans, net of taxes paid related to net share settlement     5,499 7,081    
Net cash (used in) provided by financing activities     (158,067) 356,042    
Net increase in cash, cash equivalents and restricted cash     39,532 28,440    
Cash, cash equivalents and restricted cash at beginning of period     234,695 119,219 119,219  
Cash, cash equivalents and restricted cash at end of period $ 274,227 $ 147,659 274,227 147,659 $ 234,695 $ 119,219
Supplemental disclosure of non-cash investing and financing activities:            
Amounts accrued for purchases of property and equipment     533 319    
Right-of-use assets obtained in exchange for lease obligation     1,211 970    
Debt issuances cost included in accounts payable     0 639    
Common stock issued for conversion of 2024 Convertible Notes     $ 125 $ 1,019